A clinical perspective on muscle specific kinase antibody positive myasthenia gravis

A clinical perspective on muscle specific kinase antibody positive myasthenia gravis

The discovery of autoantibodies directed against muscle-specific kinase (MuSK) in “seronegative” myasthenia gravis (MG) patients marked a milestone in MG research. In healthy muscle, MuSK regulates a phosphorylation pathway, which is essential for the development and maintenance of acetylcholine rec...

Полное описание

Библиографические подробности
Главные авторы:	Omar Keritam, Angela Vincent, Fritz Zimprich, Hakan Cetin
Формат:	Статья
Язык:	English
Опубликовано:	Frontiers Media S.A. 2024-12-01
Серии:	Frontiers in Immunology
Предметы:	muscle-specific kinase myasthenia gravis MuSK-MG IgG4 neuromuscular junction autoimmune disorder
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1502480/full

Схожие документы

MuSK Myasthenia Gravis—Potential Pathomechanisms and Treatment Directed against Specific Targets
по: Edyta Dziadkowiak, и др.
Опубликовано: (2024-03-01)

Myasthenia Gravis With Antibodies Against Muscle Specific Kinase: An Update on Clinical Features, Pathophysiology and Treatment
по: Michelangelo Cao, и др.
Опубликовано: (2020-09-01)

An Unusual Presentation of Myasthenia Gravis: Case Report
по: Sangam Yadav, и др.
Опубликовано: (2023-07-01)

Myasthenia Gravis: From the Viewpoint of Pathogenicity Focusing on Acetylcholine Receptor Clustering, Trans-Synaptic Homeostasis and Synaptic Stability
по: Masaharu Takamori
Опубликовано: (2020-05-01)

Efficacy and safety of rituximab in anti-MuSK myasthenia Gravis: a systematic review and meta-analysis
по: Siripong Chayanopparat, и др.
Опубликовано: (2025-02-01)

Myasthenia Crisis as First Presentation of MuSk Positive Myasthenia Gravis: A Case Report
по: Dipesh Chhetri, и др.
Опубликовано: (2025-02-01)

A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppression
по: Inga Koneczny, и др.
Опубликовано: (2024-04-01)

Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture
по: Inga Koneczny, и др.
Опубликовано: (2019-07-01)

New Approaches to Targeting B Cells for Myasthenia Gravis Therapy
по: Ruksana Huda
Опубликовано: (2020-02-01)

Clinical Characteristics of MuSK Antibody-positive Myasthenia Gravis in Taiwan
по: Yung-Chuan Huang, и др.
Опубликовано: (2008-07-01)

Coexistence of anti-MuSK antibody-positive myasthenia gravis and rheumatoid arthritis
по: Amber Eker, и др.
Опубликовано: (2020-08-01)

Myasthenia gravis with tongue muscle atrophy: A case series
по: Xue-Lu Zhao, и др.
Опубликовано: (2024-05-01)

Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease
по: Aigli G. Vakrakou, и др.
Опубликовано: (2023-07-01)

Efgartigimod treatment in patients with anti-MuSK-positive myasthenia gravis in exacerbation
по: Fangyi Shi, и др.
Опубликовано: (2024-11-01)

Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis
по: Mariapaola Marino, и др.
Опубликовано: (2020-05-01)

Long-Term Efficacy of Non-steroid Immunosuppressive Agents in Anti-Muscle-Specific Kinase Positive Myasthenia Gravis Patients: A Prospective Study
по: Ying Tan, и др.
Опубликовано: (2022-06-01)

Case report: Rapid clinical improvement in acute exacerbation of MuSK-MG with efgartigimod
по: Geke Zhu, и др.
Опубликовано: (2024-06-01)

The Neuromuscular Junction in Health and Disease: Molecular Mechanisms Governing Synaptic Formation and Homeostasis
по: Pedro M. Rodríguez Cruz, и др.
Опубликовано: (2020-12-01)

Overview of biomarkers in myasthenia gravis
по: Fatemeh Afrashteh, и др.
Опубликовано: (2022-10-01)

MYASTHENIA GRAVIS, DIAGNOSIS AND TREATMENT
по: A.A Gde Agung Anom Arie W, и др.
Опубликовано: (2013-05-01)

Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy
по: Miriam L. Fichtner, и др.
Опубликовано: (2022-10-01)

MIASTENIA GRAVIS ANTI-MUSK POSITIVO EM PACIENTE VIVENDO COM HIV/AIDS
по: Guilherme Ribeiro Gama, и др.
Опубликовано: (2023-10-01)

Muscle-Specific Kinase Myasthenia Gravis
по: Lucia S. Borges, и др.
Опубликовано: (2020-05-01)

Infantile Onset Myasthenia Gravis with MuSK Antibodies
по: J Gordon Millichap
Опубликовано: (2006-08-01)

MuSK-Associated Myasthenia Gravis: Clinical Features and Management
по: Carmelo Rodolico, и др.
Опубликовано: (2020-07-01)

Myasthenia gravis in clinical practice
по: Eduardo de Paula Estephan, и др.
Опубликовано: (2022-08-01)

MuSK Antibody Positive Myasthenia Gravis Mimicking as Myositis
по: Nilesh Wagh, и др.
Опубликовано: (2024-09-01)

New treatment options for generalized myasthenia gravis
по: Antanas Vaitkus, и др.
Опубликовано: (2024-02-01)

Ocular myasthenia gravis: A case series
по: Sandra C Ganesh, и др.
Опубликовано: (2020-01-01)

IMMUNOPATHOGENESIS OF MYASTHENIA GRAVIS (REVIEW)
по: E. D. Gasymly
Опубликовано: (2018-06-01)

Diagnosis and Management of Seronegative Myasthenia Gravis: Lights and Shadows
по: Claudia Vinciguerra, и др.
Опубликовано: (2023-09-01)

Possible implications of dysregulated nicotinic acetylcholine receptor diffusion and nanocluster formation in myasthenia gravis
по: Francisco J Barrantes
Опубликовано: (2021-01-01)

Physiotherapy in myasthenia gravis
по: Klaudia Kwiatkowska, и др.
Опубликовано: (2018-12-01)

Physiotherapy in myasthenia gravis
по: Klaudia Kwiatkowska, и др.
Опубликовано: (2018-12-01)

Effectiveness and Safety of Mycophenolate Mophetil in Myasthenia Gravis: A Real-Life Multicenter Experience
по: Claudia Vinciguerra, и др.
Опубликовано: (2024-07-01)

Management of Myasthenia Gravis
по: Sudhir Venkataramaiah, и др.
Опубликовано: (2019-06-01)

Muscle specific kinase (MuSK) activation preserves neuromuscular junctions in the diaphragm but is not sufficient to provide a functional benefit in the SOD1G93A mouse model of ALS
по: Arundhati Sengupta-Ghosh, и др.
Опубликовано: (2019-04-01)

Antigen specific B cells in myasthenia gravis patients
по: Kazushiro Takata, и др.
Опубликовано: (2020-04-01)

New acute onset of ocular myasthenia gravis after COVID-19 vaccine: A case report
по: Himani T. Chaturvedi, и др.
Опубликовано: (2023-02-01)

Emerging Roles of Dysregulated MicroRNAs in Myasthenia Gravis
по: Lin Wang, и др.
Опубликовано: (2020-05-01)